A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial to Evaluate the Efficacy and Safety of BMS-741672 in Patients With Diabetic Neuropathic Pain.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2009
At a glance
- Drugs BMS 741672 (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 01 May 2009 Actual number of patients added as 50.
- 01 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2008 Planned end date changed from 1 Jan 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.